Factors responsible for the evolution of insulin resistance in Japanese type 2 diabetic patients: Association with atherosclerosis

Diabetes Research and Clinical Practice

Volumn 77, Issue 3 SUPPL., 2007, Pages

  Taniguchi, Ataru ^a   Fukushima, Mitsuo ^b   Nakai, Yoshikatsu ^c   Kuroe, Akira ^a   Ohya, Michihiro ^a   Ohgushi, Minako ^a   Seino, Yutaka ^a  

^a KANSAI DENRYOKU HOSPITAL   (Japan)

^b FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^c Karasuma Nakai Clinic   (Japan)

Author keywords

Atherosclerosis; Insulin; Type 2 diabetic patients

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INSULIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; ASIAN; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; ETHNIC GROUP; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; JAPAN; NON INSULIN DEPENDENT DIABETES MELLITUS; RACE DIFFERENCE; RISK FACTOR; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ATHEROSCLEROSIS; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS; INSULIN RESISTANCE; JAPAN; LEPTIN; TRIGLYCERIDES;

EID: 34547653771     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.01.060     Document Type: Article

References (40)

1. Gerich J.E. The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr. Rev. 19 (1998) 491-503 (Review)
2. Bergman R.N. Toward physiological understanding of glucose tolerance: minimal-model approach. Diabetes 38 (1989) 1512-1527
3. Welch S., Gebhart S.S.P., Bergman R.N., and Phillips L.S. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J. Clin. Endocrinol. Metab. 71 (1990) 1508-1518
4. Taniguchi A., Nakai Y., Fukushima M., Kawamura H., Imura H., Nagata I., et al. Pathogenic factors responsible for glucose intolerance in patients with NIDM. Diabetes 41 (1992) 1540-1546
5. Nagasaka S., Tokuyama K., Kusaka I., Hayashi H., Rokkaku K., Nakamura T., et al. Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach. Diabetes 48 (1999) 1054-1060
6. Taniguchi A., Nakai Y., Tokuyama K., Sakai M., Doi K., Fukushima M., et al. Role of glucose effectiveness in the evolution of NIDDM. In: Bergman R.N., and Lovejoy J.C. (Eds). The Minimal Model Approach and Determinants of Glucose Tolerance. Pennington Center Nutrition Series, vol. 7 (1997), Louisiana State University Press, Baton Rouge and London 357-367
7. Haffner S.M., D'Agostino Jr. R., Mykkanen L., Tracy R., Howard B., Rewers M., et al. Insulin sensitivity in subjects with type 2 diabetes: relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care 14 (1991) 1036-1042
8. Fukushima M., Usami M., Ikeda M., Nakai Y., Taniguchi A., Suzuki H., et al. Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes. Metabolism 53 (2004) 831-835
9. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
10. Fukushima M., Taniguchi A., Sakai M., Doi K., Nagasaka S., Tanaka H., et al. Homeostasis model assessment as a clinical index of insulin resistance. Comparison with the minimal model analysis (letter). Diabetes Care 22 (1999) 1911-1912
11. Taniguchi A., Fukushima M., Sakai M., Kataoka K., Nagata I., Doi K., et al. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients. Metabolism 49 (2000) 1001-1005
12. Taniguchi A., Fukushima M., Sakai M., Miwa K., Makita T., Nagata I., et al. Remnant-like particle cholesterol, triglycerides, and insulin resistance in non-obese Japanese type 2 diabetic patients. Diabetes Care 23 (2000) 1766-1769
13. Taniguchi A., Fukushima M., Sakai M., Tokuyama K., Nagata I., Fukunaga A., et al. Effects of bezafibrate on insulin sensitivity and insulin secretion in non-obese Japanese type 2 diabetic patients. Metabolism 50 (2001) 477-480
14. Kishimoto H., Taniguchi A., Fukushima M., Sakai M., Tokuyama K., Oguma T., et al. Effect of short-term low-intensity exercise on insulin sensitivity, insulin secretion, and glucose and lipid metabolism in non-obese Japanese type 2 diabetic patients. Horm. Metab. Res. 34 (2002) 27-31
15. Kugiyama K., Doi H., Takazoe K., Kawano H., Soejima H., Mizuno Y., et al. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation 99 (1999) 2858-2860
16. Taniguchi A., Nakai Y., Sakai M., Yoshii S., Hayashi M., Nishitani K., et al. Relationship of regional adiposity to insulin resistance in non-obese Japanese type 2 diabetic patients (letter). Diabetes Care 24 (2001) 966-968
17. Okumura T., Taniguchi A., Nagasaka S., Sakai M., Fukushima M., et al. Relationship of regional adiposity to serum leptin level in non-obese Japanese type 2 diabetic male patients. Diabetes Metab. 29 (2003) 15-18
18. Yatagi T., Nagasaka S., Taniguchi A., Fukushima M., Nakamura T., Kuroe A., et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 52 (2003) 1274-1278
19. Taniguchi A., Nakai Y., Sakai M., Yoshii S., Hamanaka D., Hatae Y., et al. Relationship of regional adiposity to insulin resistance and serum triglyceride levels in non-obese Japanese type 2 diabetic patients. Metabolism 51 (2002) 544-548
20. Taniguchi A., Nagasaka S., Fukushima M., Sakai M., Okumura T., Yoshii S., et al. C-reactive protein and insulin resistance in non-obese Japanese type 2 diabetic patients. Metabolism 51 (2002) 1578-1581
21. Taniguchi A., Fukushima M., Nakai Y., Kuroe A., Yamano G., Yanagawa T., et al. Soluble E-selectin, leptin, triglycerides, and insulin resistance in non-obese Japanese type 2 diabetic patients. Metabolism 54 (2005) 376-380
22. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Heinekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Eng. J. Med. 336 (1997) 973-979
23. Erbe D.V., Barry A., Presta L.G., Norton C.R., Ramos R.J., Burns D.K., et al. Identification of an E-selectin region critical from carbohydrate recognition and cell adhesion. J. Cell. Biol. 119 (1992) 215-217
24. Yanagawa T., Taniguchi A., Fukushima M., Nakai Y., Nagasaka S., Ohgushi M., et al. Leptin, triglycerides, and interleukin 6 are independently associated with C-reactive protein in Japanese type 2 diabetic patients. Diabetes Res. Clin. Pract. 75 (2007) 2-6
25. Ohya M., Taniguchi A., Fukushima M., Nakai Y., Kawasaki Y., Nagasaka S., et al. Three measures of tumor necrosis factor-α activity and insulin resistance in non-obese Japanese type 2 diabetic patients. Metabolism 54 (2005) 1297-1301
26. Hotamisligil G.S., and Spiegelman B.M. Tumor necrosis factor-α: a key component of the obesity-diabetes link. Diabetes 43 (1994) 1271-1278
27. Pittas A.G., Joseph N.A., and Greenberg A.S. Adipocytokines and insulin resistance. J. Clin. Endocrinol. Metab. 89 (2004) 447-452
28. Hotamisligil G.H., Arner O., Caro J.F., Atkinson R.L., and Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest. 95 (1995) 2409-2415
29. Dandona P., Weinstock R., Thuse A., Abdel-Rahman E., Aljada A., and Wadden T. Tumor necrosis factor-α in sera of obese patients: fall with weight loss. J. Clin. Endocrinol. Metab. 83 (1998) 2907-2910
30. Katsuki A., Sumida Y., Murashima S., Murata K., Takarada Y., Ito K., et al. Serum levels of tumor necrosis factor-α are increased in obese patients with non-insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 83 (1998) 859-862
31. Kellerer M., Rett K., Renn W., Groop L., and Haring H.U. Circulating TNF-alpha and leptin levels in offsprings of NIDDM patients do not correlate to individual insulin sensitivity. Horm. Metab. Res. 29 (1997) 111-114
32. Zavarotoni I., Numeroso F., Dongiovanni P., Ardigo D., Valenti L., Francanzani A.L., et al. What is the contribution of differences in three measures of tumor necrosis factor-alpha activity to insulin resistance in healthy volunteers?. Metabolism 52 (2003) 1593-1596
33. Ofei F., Hurel S., Newkirk J., Sopwith M., and Taylor R. Effects of an engineered human anti-TBF0-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 45 (1996) 881-885
34. Paquot N., Castillo M.J., Lefebvee P.J., and Scheen A.J. No increased insulin sensitivity after a single administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin resistant patients. J. Clin. Enodocrinol. Metab. 85 (2000) 1316-1319
35. Rauchhaus M., Doehner W., Francis D.P., Davos C., Kemp M., Liebenthal C., et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102 (2000) 3060-3067
36. Kawasaki Y., Taniguchi A., Fukushima M., Nakai Y., Kuroe A., Ohya M., et al. Soluble TNF receptors and albuminuria in non-obese Japanese type 2 diabetic patients. Horm. Metab. Res. 37 (2005) 617-621
37. Taniguchi A., Fukushima M., Nakai Y., Ohgushi M., Kuroe A., Ohya M., et al. Soluble tumor necrosis factor receptor 1 is strongly and independently associated with serum homocysteine in non-obese Japanese type 2 diabetic patients (letter). Diabetes Care 29 (2006) 949-950
38. Refsum H., and Ueland M. Homocystene and cardiovascular disease. Annu. Rev. Med. 49 (1998) 31-62
39. Shai I., Schulze M.B., Manson J.E., Rexrode K.M., Stampfer M.J., Mantzoros C., et al. A prospective study of soluble tumor necrosis factor-α receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes. Diabetes Care 28 (2005) 1376-1382
40. Ohgushi M., Taniguchi A., Fukushima M., Nakai Y., Kuroe A., Ohya M., et al. Soluble tumor necrosis factor receptor 2 is independently associated with pulse wave velocity in nonobese Japanese patients with type 2 diabetes mellitus. Metabolism 56 (2007) 571-577